.Attribute Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for incorporation of people along with MASLD and also measurement of liver outcomes in cardio-- renal-- metabolic trials, when records propose mechanistically possible advantages and also professional protection-- as well as lays out factors for trial layout and also governing approval.